Mahdi Saghari

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Randomized Controlled Trial

Atopic Dermatitis

Top Venues

Experimental dermatology

British journal of clinical pharmacology

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Jannik Rousel, Andreea Nadaban, Mahdi Saghari, Lisa Pagan, Ahnjili Zhuparris, Bart Theelen, Tom Gambrah, Hein E C van der Wall, Rob J Vreeken, Gary L Feiss, Tessa Niemeyer-van der Kolk, Jacobus Burggraaf, Martijn B A van Doorn, Joke A Bouwstra, Robert Rissmann
Lesional skin of seborrheic dermatitis patients is characterized by skin barrier dysfunction and correlating alterations in the stratum corneum ceramide composition. Experimental dermatology (2023)
Wouter Ten Voorde, Mahdi Saghari, Jiry Boltjes, Marieke L de Kam, Ahnjili Zhuparris, Gary Feiss, Thomas P Buters, Errol P Prens, Jeffrey Damman, Tessa Niemeyer van der Kolk, Matthijs Moerland, Jacobus Burggraaf, Martijn Bastiaan Adriaan van Doorn, Robert Rissmann
A multimodal, comprehensive characterization of a cutaneous wound model in healthy volunteers. Experimental dermatology (2023)
Jannik Rousel, Mahdi Saghari, Lisa Pagan, Andreea Nadaban, Tom Gambrah, Bart Theelen, Marieke L de Kam, Jorine Haakman, Hein E C van der Wall, Gary L Feiss, Tessa Niemeyer-van der Kolk, Jacobus Burggraaf, Joke A Bouwstra, Robert Rissmann, Martijn B A van Doorn
Treatment with the Topical Antimicrobial Peptide Omiganan in Mild-to-Moderate Facial Seborrheic Dermatitis versus Ketoconazole and Placebo: Results of a Randomized Controlled Proof-of-Concept Trial. International journal of molecular sciences 24 (18) (2023)
Mahdi Saghari, Pim Gal, Dimitrios Ziagkos, Jacobus Burggraaf, John F Powell, Nuala Brennan, Robert Rissmann, Martijn B A van Doorn, Matthijs Moerland
A randomized controlled trial with a delayed-type hypersensitivity model using keyhole limpet haemocyanin to evaluate adaptive immune responses in man. British journal of clinical pharmacology 87 (4) (2020)